Liabilities / Assets
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
990EZ • Fiscal year 2015 • EIN 46-4061449
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
Score unavailable
Net margin requires both revenue and expenses on this filing.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
9th percentile
Faster asset growth than 9% of similar nonprofits.
Revenue Growth
1st percentile
Faster revenue growth than 1% of similar nonprofits.
Assets
Down$31,469
Down $30,533 (-49%) from 2014
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down$0
Down $8,815 (-100%) from 2014
Revenue
Down$0
Down $57,183 (-100%) from 2014
Expenses
Up$21,718
Up $17,722 (+443%) from 2014
Net Income
Down-$21,718
Down $74,905 (-141%) from 2014
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To transform the lives of patients with neurological diseases including alzheimer's, parkinson's, lou gehrig's disease, multiple sclerosis, spinal cord and acquired head injury with collaborative translational research. The halo effect is our belief that neurological conditions share a common denominator at the cellular, molecular and genetic level. This means that when we find solutions for one condition, this will lead us to new advances for other neurological deficits that will improve patients' quality of life. At neurocures our translational research is transforming the lives of patients today while advancing the cures of tomorrow.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990EZSummary only. Only limited summary data is available for this year.